Emerging data indicate that G protein-coupled receptors (GPCRs) play important roles in the pathogenesis of cancers. Many GPCRs are constitutively overexpressed in various cancers, and their aberrant signaling is implicated in different stages of tumorigenesis and metastasis. For GPCRs to mediate signaling, one proposed mechanism involves formation of GPCR homo-and hetero-oligomers. However, certain details of the process remain unknown. To address this, we combine pointillistic super-resolution methods and paircorrelation analysis to quantitatively characterize GPCR oligomerization domains both with single molecule sensitivity and at nanometer scale precision. With this approach, we systematically investigated healthy/cancerous cells and multicellular tumor spheroids -a 3D tumor model. Our data suggests that overexpression of mu and kappa opioid receptors induces formation of dense oligomers with both short-and long-distance organization (also supported by fluorescence correlation spectroscopy measurements). Additionally, endogenous oligomers of various sizes are evident in pancreatic cancer cells; these include opioid receptors, somatostatin receptor 2, chemokine C-X-C motif receptor 4, and chemokine C-C motif receptor 5. Importantly, the results suggest that somatostatin receptor 2 associates with mu opioid receptor (i.e. forms hetero-oligomers) in pancreatic cancer cells and multicellular tumor spheroids. In the future, successful application of this innovative approach can be used as a tool for quantitative screening of GPCRs and drug discovery. Ultimately, this strategy may produce novel markers and therapeutic targets for pancreatic cancer.
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Real Time Observation of Ligand Binding to a GPCR: Conformational Selection Governs the Ability of Retinals to Bind Opsin Christopher T. Schafer, David L. Farrens. OHSU, Portland, OR, USA. Despite extensive study, how retinal enters and exits the visual G proteincoupled receptor (GPCR) rhodopsin remains unclear. One clue may lie in two openings between TM1/TM7 and TM5/TM6 in the active receptor state. Recently, it has been proposed that retinal enters the inactive apoprotein (ops) when the receptor transiently adopts the open, active (ops*) conformation. Here, we directly tested this ''transient activation'' hypothesis (TAH), using a fluorescence-based approach to measure rates of retinal binding to samples containing differing amounts of ops and ops*. In contrast to what the TAH would predict, we found the inverse agonist, 11-cis retinal (11CR), binding is slower to a sample that contained more ops* (produced using the constitutively active mutant M257Y_M257Y-CAM). Interestingly, the increased presence of ops* allowed for binding of the agonist, all-trans retinal (ATR) faster, whereas WT opsin showed none. Further weighting the conformational equilibrium towards even more ops* using a G protein peptide mimic (either free in solution or fused to the receptor) accelerated the rate of ATR binding and slowed 11CR binding. Similar results were obtained using a peptide mimetic of arrestin. The TM5/TM6 hole does not appear to be sufficient for this conformational selection as increasing the size of this opening by mutagenesis does not enable ATR binding. Unexpectedly, the larger hole slows 11CR binding, suggesting a role in trapping the inverse agonist. In summary, our results indicate that the TAH must be modified to accommodate the key role conformational selection plays in stable retinal binding. Additionally, we show that rhodopsin behaves similarly to ligand-binding GPCRs with respect to exogenous ligand interactions, indicating a role for the visual receptor as a model for hydrophobic ligand binding. The superfamily of G Protein-Coupled Receptors (GPCRs) is one of the largest in the human genome. GPCRs are targets for about a quarter of all prescription drugs. Recent progress in the structural biology of GPCRs renews the interest in rational drug design and discovery. Rational design of ''functionally selective'' drugs or ligands presents a particularly difficult problem. Agonist ligands frequently display functional selectivity where activated receptors are biased to either G protein-or arrestin-mediated downstream signaling pathways. However, functional characterization of GPCRs has largely been limited to cellbased high-throughput screening assays. The complexity of the cellular milieu introduces biological variables that make quantitative analysis of structure and dynamics of ligand-receptor complexes that underlie functional selectivity virtually impossible. We are developing single-molecule fluorescence methods to eliminate this biological noise and study such complexes in biochemicallydefined systems.
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[1] Systematic introduction of signaling partners, such as G proteins and arrestins, enables us to study their allosteric effects on ligandreceptor interactions. Recent methodological advances enabled us to express GPCRs with genetically-encoded unnatural amino acids (uaas). We showed that bioorthogonal functional groups on these site-specifically introduced uaas might be used for bioorthogonal reactions. Among a broad spectrum of bioorthogonal reactions, strain-promoted azide-alkyne cycloaddition (SpAAC) with the uaa p-azido-phenylalanine and dibenzocyclooctyne (DIBO) reagents is specific and efficient and presents the best option to obtain stoichiometric receptor-fluorophore conjugates. We designed and built a fully-automatic, multi-color, single-molecule detection fluorescence microscope for longtimescale, multiplexed data acquisition using a multi-well tethered membrane ''chip'' system. Our convergent technology platform presents a new approach for single-molecule fluorescence studies of the kinetics and dynamics of GPCR signalosomes.
[1] T. Huber and T.P. Sakmar. Chemical Biology Methods for Investigating G Protein-Coupled Receptor Signaling. Chem Biol. 18:1224 Biol. 18: -1237 Biol. 18: (2014 487-Pos Board B267 Polymer-Based Nanodiscs for Studying Structure and Dynamics of G-Protein-Coupled Receptors Jana Broecker 1 , Takefumi Morizumi 1 , Wei-Lin Ou 1 , Oliver P. Ernst 1,2 . 1 Biochemistry, University of Toronto, Toronto, ON, Canada, 2 Molecular Genetics, University of Toronto, Toronto, ON, Canada. G-protein-coupled receptors (GPCRs) constitute the largest family of membrane proteins and are most important drug targets. Understanding of their inner workings is only in the beginning, because as integral membrane proteins GPCRs require the use of detergents to solubilize them into an aqueous environment for purification and subsequent biophysical and structural studies. Detergent micelles, however, are limited in their ability to mimic lipid bilayers. Recently, a promising approach was introduced that overcomes these detergent-related drawbacks: poly(styrene-co-maleic acid), a copolymer synthesized from styrene and maleic anhydride, has been shown to solubilize membrane proteins from various membranes without the need of detergents. In the resulting nanometer-sized nanodiscs the polymer wraps around the protein and its annular lipids. Here, we address the question to which extent polymer-based nanoparticles are able to stabilize a GPCR and how they influence protein activity and functionality. We compared activation of the GPCR and photoreceptor bovine rhodopsin and its equilibrium of metarhodopsin (Meta) photo-products for rhodopsin solubilized either in n-dodecyl-b-D-maltoside (DDM) detergent micelles or as polymer nanodiscs. While DDM favors active Meta II, the polymer-based environment favors the inactive Meta I and Meta III states, which might explain the lack of G-protein activation in the latter case. Protein function is reestablished as soon as rhodopsin is transferred from the discs into detergent micelles or proteoliposomes. In contrast to DDM, the polymer belt also affects the binding of 11-cis-retinal ligand. Taken together, polymer nanodiscs are suited to extract GPCRs from native membranes in a detergent-free manner but appear to exert a rather rigid lipid environment prohibiting helical movements. The presented work is part of a study where we test various membrane-mimetic systems for studying structure and dynamics of GPCRs and other proteins related to Structural Neurobiology. 96a Sunday, February 8, 2015 
